The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
For GMG to make sense as an investment, you have to believe its graphene platform can turn breakthrough lab results into commercial products before funding pressures bite. The latest graphene aluminium-ion battery update, with sub-six-minute charging, defined customer testing timelines and a plastic pack design aimed at cost and safety, strengthens the “technology option” part of the story and helps explain the very large share price move this year. In the near term, the main catalysts now sit around hitting those 2026–2027 milestones and converting early interest in G-LUBRICANT and THERMAL-XR into meaningful A$ revenue, against a backdrop of small sales and rising losses. The flip side is execution and capital risk: scaling advanced batteries and coatings from such a low revenue base will not be cheap or straightforward.
However, one key funding-related risk may be easier to overlook than the battery headlines. Graphene Manufacturing Group's shares have been on the rise but are still potentially undervalued by 47%. Find out what it's worth.Six fair value estimates from the Simply Wall St Community span from penny-stock levels to above the latest analyst target, underscoring how far apart views are on GMG. Set against that, the battery progress and sharp share price rise put more pressure on the company to validate its timelines and manage cash carefully, which could matter a lot for how the story develops from here.
Explore 6 other fair value estimates on Graphene Manufacturing Group - why the stock might be worth less than half the current price!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com